Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
And our lowest-price guarantee means you'll never overpay
update to: Management of hyperglycemia in type 2 diabetes, 2018
MT-1 is a linear tridecapeptide preferentially activating MC1R and producing predominantly peripheral pigmentation and photoprotection biology with minimal central melanocortin receptor effects at research doses
While meta-analyses show no adverse renal effects in healthy individuals, the data in people with established kidney disease is limited
US$ 29.40
US$ 22.94
US$ 28.88
US$ 29.33
US$ 26.59
US$ 29.88
